Cargando…

Germline breast cancer susceptibility gene mutations and breast cancer outcomes

BACKGROUND: It is unclear whether germline breast cancer susceptibility gene mutations affect breast cancer related outcomes. We wanted to evaluate mutation patterns in 20 breast cancer susceptibility genes and correlate the mutations with clinical characteristics to determine the effects of these g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yong Alison, Jian, Jhih-Wei, Hung, Chen-Fang, Peng, Hung-Pin, Yang, Chi-Fan, Cheng, Hung-Chun Skye, Yang, An-Suei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863855/ https://www.ncbi.nlm.nih.gov/pubmed/29566657 http://dx.doi.org/10.1186/s12885-018-4229-5

Ejemplares similares

Evaluating BRCA mutation risk predictive models in a Chinese cohort in Taiwan
por: Hung, Fei-Hung, et al.
Publicado: (2019)

Locoregional therapy in luminal-like and HER2-enriched patients with de novo stage IV breast cancer
por: Chen, Peng-Yu, et al.
Publicado: (2013)

Germline breast cancer susceptibility genes, tumor characteristics, and survival
por: Ho, Peh Joo, et al.
Publicado: (2021)

Development of a prediction model for breast cancer based on the national cancer registry in Taiwan
por: Huang, Ching-Chieh, et al.
Publicado: (2019)

Germline mutations in Chinese ovarian cancer with or without breast cancer
por: Kwong, Ava, et al.
Publicado: (2022)

Germline Mutational Landscape in Chinese Patients With Advanced Breast Cancer
por: Zhang, Jiayang, et al.
Publicado: (2022)

Germline BRCA2 mutations in men with breast cancer.
por: Mavraki, E., et al.
Publicado: (1997)

Germline and Somatic mutations in postmenopausal breast cancer patients
por: Nagy, Tauana Rodrigues, et al.
Publicado: (2021)

Predicting Ligand Binding Sites on Protein Surfaces by 3-Dimensional Probability Density Distributions of Interacting Atoms
por: Jian, Jhih-Wei, et al.
Publicado: (2016)

Gene expression profiling in prognosis of distant recurrence in HR-positive and HER2-negative breast cancer patients
por: Huang, Tzu-Ting, et al.
Publicado: (2018)

Germline mutation landscape of Chinese patients with familial breast/ovarian cancer in a panel of 22 susceptibility genes
por: Wang, Jiayu, et al.
Publicado: (2019)

Validation of the 18-gene classifier as a prognostic biomarker of distant metastasis in breast cancer
por: Cheng, Skye Hung-Chun, et al.
Publicado: (2017)

A new clinical-genomic model to predict 10-year recurrence risk in primary operable breast cancer patients
por: Huang, Tzu-Ting, et al.
Publicado: (2020)

Germline mutational spectrum in Armenian breast cancer patients suspected of hereditary breast and ovarian cancer
por: Moradian, Mike M., et al.
Publicado: (2021)

Germline TP53 mutations in Finnish breast cancer patients
por: Rapakko, K, et al.
Publicado: (2000)

Clinical implications of germline mutations in breast cancer: TP53
por: Schon, Katherine, et al.
Publicado: (2017)

Clinical implications of germline mutations in breast cancer genes: RECQL
por: Bowden, A. Ramsay, et al.
Publicado: (2019)

Screening of germline mutations in young Rwandan patients with breast cancers
por: Uyisenga, Jeanne P., et al.
Publicado: (2020)

The contribution of hereditary cancer-related germline mutations to lung cancer susceptibility
por: Liu, Mengyuan, et al.
Publicado: (2020)

A role of BRCA1 and BRCA2 germline mutations in breast cancer susceptibility within Sardinian population
por: Palomba, Grazia, et al.
Publicado: (2009)

Analysis of EZH2 Genetic Variants on Triple-Negative Breast Cancer Susceptibility and Pathology
por: Liu, Liang-Chih, et al.
Publicado: (2022)

DGM-CM6: A New Model to Predict Distant Recurrence Risk in Operable Endocrine-Responsive Breast Cancer
por: Lei, Lei, et al.
Publicado: (2020)

Mutation spectrum of germline cancer susceptibility genes among unselected Chinese colorectal cancer patients
por: Gong, Rui, et al.
Publicado: (2019)

Mutation screening of germline TP53 mutations in high-risk Chinese breast cancer patients
por: Kwong, Ava, et al.
Publicado: (2020)

Sequencing for germline mutations in Swedish breast cancer families reveals novel breast cancer risk genes
por: Helgadottir, Hafdis T., et al.
Publicado: (2021)

Prevalence and clinical significance of BRCA1/2 germline and somatic mutations in Taiwanese patients with ovarian cancer
por: Chao, Angel, et al.
Publicado: (2016)

Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes
por: Mavaddat, Nasim, et al.
Publicado: (2022)

Prognostic Comparison between Oncotype DX(®) and a 23-Gene Classifier, RecurIndex(®), on the Taiwan Breast Cancer Population
por: Chang, Chuan-Hsun, et al.
Publicado: (2022)

Germline PALB2 Mutations in Cancers and Its Distinction From Somatic PALB2 Mutations in Breast Cancers
por: Hu, Zhe-Yu, et al.
Publicado: (2020)

Predicted Chemotherapy Benefit for Breast Cancer Patients With Germline Pathogenic Variants in Cancer Susceptibility Genes
por: Kurian, Allison W, et al.
Publicado: (2020)

Contribution of BRCA1 germline mutation in patients with sporadic breast cancer
por: Malik, Fraz A, et al.
Publicado: (2008)

RAD51C germline mutations in breast and ovarian cancer patients
por: Akbari, Mohammad R, et al.
Publicado: (2010)

Germline TP53 mutational spectrum in French Canadians with breast cancer
por: Arcand, Suzanna L, et al.
Publicado: (2015)

Effects of BRCA Germline Mutations on Triple-Negative Breast Cancer Prognosis
por: Pogoda, Katarzyna, et al.
Publicado: (2020)

Germline Mutation Analysis in Sporadic Breast Cancer Cases With Clinical Correlations
por: Ajaz, Sadia, et al.
Publicado: (2022)

A germline missense mutation in COQ6 is associated with susceptibility to familial schwannomatosis
por: Zhang, Keqiang, et al.
Publicado: (2014)

Cost-Effectiveness Analysis from a Societal Perspective of Recurrence Index for Distant Recurrence (RecurIndex) in Women with Hormone Receptor-Positive and HER2-Negative Early-Stage Breast Cancer
por: Pennarun, Nicolas, et al.
Publicado: (2022)

RNA-seq transcriptome analysis of breast cancer cell lines under shikonin treatment
por: Lin, Kuo-Hua, et al.
Publicado: (2018)

Does hepatectomy improve outcomes of breast cancer with liver metastasis? A nationwide analysis of real-world data in Taiwan
por: Chen, Pin-Chun, et al.
Publicado: (2022)

Germline copy number variations associated with breast cancer susceptibility in a Japanese population
por: Suehiro, Yutaka, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_pqgru0blacqllftho6fa11qlto